MS-PFMEDIUM SIGNALFINANCIAL10-Q

Morgan Stanley reported improved profitability with ROE expanding to 18.0% from 13.9% and meaningfully better operating cash flow generation quarter-over-quarter.

The firm demonstrated strong operational momentum with both Institutional Securities and Wealth Management segments showing revenue growth, while expense efficiency improved to 67% from 71%. The combination of higher net income, substantially improved cash flow generation, and maintained strong capital ratios (15.1% CET1) suggests effective execution across business lines during a favorable market environment.

Comparing 2025-11-03 vs 2025-08-04View on EDGAR →
FINANCIAL ANALYSIS

Morgan Stanley's financial position strengthened meaningfully with net income growing 20.8% to $5.6B and operating cash flow improving substantially from negative $24.0B to negative $7.1B. The balance sheet expanded with total assets growing 11.3% to $1.6T and cash positions increasing 19.5% to $133.5B, while the firm returned more capital to shareholders through increased buybacks. The overall picture signals improved profitability and cash generation capability while maintaining a robust capital foundation.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+70.4%
-$24.0B-$7.1B

Operating cash flow surged 70.4% — exceptional cash generation, highest quality earnings signal.

Share Buybacks
Cash Flow
+67.2%
$183.0M$306.0M

Share repurchases increased 67.2% — management returning capital, signals confidence in intrinsic value.

Net Income
P&L
+20.8%
$4.6B$5.6B

Net income grew 20.8% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+19.5%
$111.7B$133.5B

Cash grew 19.5% — improving liquidity position supports investment and shareholder returns.

Total Liabilities
Balance Sheet
+12.1%
$1.3T$1.5T

Liabilities increased 12.1% — monitor debt-to-equity ratio and interest coverage.

Total Assets
Balance Sheet
+11.3%
$1.4T$1.6T

Asset base grew 11.3% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2025-11-03
PRIOR — 2025-08-04
ADDED
The Firm delivered ROE of 18.0% and ROTCE of 23.5% (see Selected Non-GAAP Financial Information herein).
The Firm s expense efficiency ratio was 67% for the third quarter and 69% for the year-to-date.
At September 30, 2025, the Firm s Standardized Common Equity Tier 1 capital ratio was 15.1%, and its Supplementary Leverage Ratio was 5.5%.
Institutional Securities reported net revenues of $8.5 billion reflecting strong performance in Equity on higher client activity and a rebound in Investment Banking .
Net revenues of $8.2 billion reflect higher Asset management and Transactional revenues and higher Net interest income.
+7 more — sign up free →
REMOVED
The Firm delivered ROE of 13.9% and ROTCE of 18.2% (see Selected Non-GAAP Financial Information herein).
The Firm s expense efficiency ratio was 71% for the second quarter and 70% for the year-to-date reflecting continued discipline in controllable spend, benefits from prior occupancy exits, and productivity gains through technology, partially offset by higher execution-related expenses.
At June 30, 2025, the Firm s Standardized Common Equity Tier 1 capital ratio was 15.0%.
Institutional Securities reported net revenues of $7.6 billion reflecting strong performance in our Markets business on higher client activity primarily in Equity.
Net revenues of $7.8 billion reflect higher Asset management revenues and higher Transactional revenues driven by increased client activity and the positive impact of investments associated with certain employee deferred cash-based compensation plans linked to investment performance ( DCP investments ) of $294 million.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →